Site Editor

Sandy Srinivas, MD

Advertisement

Advertisement

JNCCN Spotlights

Degarelix (Injectable GnRH Antagonist)

News

AACR 2021: Role of a Healthy Lifestyle in Offsetting Genetic Risks for Prostate Cancer

Medical Literature

Stereotactic Body Radiotherapy for High-Risk Localized Prostate Cancer

News

AACR 2021: Prostate Cancer Risk, Obesity, and Diabetes

News

Are Antiepileptic Drugs Linked to Reduced Risk of Prostate Cancer?

Medical Literature

Effect of Androgen-Deprivation Therapy on Systemic Symptomatology in Men With Prostate Cancer

Medical Literature

Plasma Cells and Immune Responsiveness in Black Men With Prostate Cancer

Daniel P. Petrylak, MD, on Understanding ARV-110, an Oral PROTAC Degrader for Prostate Cancer Treatment

Felix Y. Feng, MD, on Predicting the Efficacy of Apalutamide in Patients With Castration-Resistant Prostate Cancer

View More

Advertisement

JNCCN Spotlights

Apalutamide (Erleada^™)

Docetaxel (Castration-Naive Metastatic Prostate Cancer)

(UPDATE) Enzalutamide (Xtandi®)

Degarelix (Injectable GnRH Antagonist)

View More

More

News

Novel Immunotherapy Combination in Metastatic Prostate Cancer Moves on to Phase II

Are Genetic Factors Potentially Driving Prostate Cancer in Black Individuals?

Radical Prostatectomy Versus Radiotherapy for Localized Ductal Prostate Cancer

GU Symposium 2021: Adding Pembrolizumab to Radium-223 for Metastatic Castration-Resistant Prostate Cancer

GU Symposium 2021: Final ACIS Results on Apalutamide-Based Therapy for Metastatic Prostate Cancer

Erectile Dysfunction and Sexual Satisfaction After Robot-Assisted Radical Prostatectomy

GU Symposium 2021: Novel Tool for Predicting Metastasis After Radiotherapy for Prostate Cancer

Final Analysis of PROfound Trial: Olaparib in Metastatic Castration-Resistant Prostate Cancer

View More

Advertisement

Published

Medical Literature

Link Between Polypharmacy and Inpatient Hospitalization in Older Patients With Prostate Cancer?

Concurrent Enzalutamide, Salvage Radiotherapy, and ADT in High-Risk Prostate Cancer

Height/Weight in Early Adulthood and Risk of Prostate Cancer

Conventional Fractionated Versus Hypofractionated Radiation for Prostate Cancer: A 10-Year Update

View More

Ongoing

CE Activities

Nursing Management of Treatment-Related Side Effects in Metastatic Prostate Cancer

Current and Emerging Treatment Options for Genitourinary Cancers (Prostate Cancer, Renal Cell Carcinoma and Urothelial Carcinoma)

MRI With Targeted Biopsy Matches Current Standard for ID'ing Prostate Cancer

Active Surveillance for Low-Risk Prostate Cancer Affected by Where Men Live

View More

Available

Clinical Trials

University of Nebraska

Seidman Cancer Center

City of Hope

Dana-Farber Cancer Institute

View More

Resources

For Your Patients

NCCN Guidelines for Patients®: Prostate Cancer

National Alliance of State Prostate Cancer Coalitions (NASPCC)

Prostate Conditions Education Council (PCEC)

Cancer.Net

View More

Sections

360 Hub

NCCN Resources

Copyright^© 2021 National Comprehensive Cancer Network, All Rights Reserved

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.